- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Small Cell Lung Cancer ALK-positive in United Kingdom
Total 10990 results
-
Massachusetts General HospitalNational Cancer Institute (NCI)TerminatedNon-small Cell Lung CancerUnited States
-
Heat BiologicsWithdrawnNon-small Cell Lung CancerUnited States
-
Sun Farm CorporationNational Center for Complementary and Integrative Health (NCCIH)UnknownNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaboratorsCompletedNon-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited Kingdom
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
CellSight Technologies, Inc.University of Iowa Hospitals & ClinicsNot yet recruiting
-
Muhammad FurqanRecruitingNon-small Cell Lung CancerUnited States
-
State University of New York - Upstate Medical...RecruitingNon-small Cell Lung CancerUnited States
-
Albert Einstein College of MedicineCompletedNon-small Cell Lung CancerUnited States
-
Sue YomMerck Sharp & Dohme LLCCompletedNon Small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedNon-small Cell Lung CancerUnited States
-
Jeffrey ClarkeCompletedNon-small Cell Lung CancerUnited States
-
Duke UniversityCompleted
-
Leo W. Jenkins Cancer CenterEast Carolina UniversityTerminated
-
West Virginia UniversityCelgene CorporationWithdrawnNon-small Cell Lung CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Extensive Stage Small Cell Lung Carcinoma | Squamous Cell Lung Carcinoma | Recurrent Small Cell Lung CarcinomaUnited States
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Lung Non-Small Cell Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7United States, Canada
-
Dana-Farber Cancer InstituteRecruitingSmall Cell Lung Carcinoma | Non Small Cell Lung CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLung Cancer | Non-small Cell Lung CancerUnited States
-
Duke UniversityBristol-Myers SquibbTerminatedNon Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung CancerUnited States
-
Aetion, Inc.CompletedMetastatic Lung Cancer | Non-small Cell Lung CancerUnited States
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage IIIUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | EGFR Activating Mutation | Stage IV Non-Small Cell Lung Cancer AJCC v7 | ALK Gene Translocation | Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | ROS1 Gene TranslocationUnited States
-
University of ChicagoGenentech, Inc.CompletedAdvanced Non-squamous Non-Small Cell Lung CancerUnited States
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer | Cancer of the Head and NeckPoland, Germany, Hungary, United Kingdom
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingNon-small Cell Lung CancerUnited States
-
New Mexico Cancer Care AllianceUniversity of New Mexico Cancer Center; Lovelace Respiratory Research InstituteTerminatedNon-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerItaly, Spain, Netherlands, France, Germany, United Kingdom
-
Verastem, Inc.AmgenRecruitingNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, United Kingdom, Netherlands, Belgium
-
Abramson Cancer Center of the University of PennsylvaniaCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.RecruitingTriple Negative Breast Cancer | Non-small Cell Lung Cancer | Hormone Receptor Positive Breast CancerUnited States, Japan
-
Providence Health & ServicesBristol-Myers Squibb; Genentech, Inc.TerminatedNon-squamous Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
ETOP IBCSG Partners FoundationEuropean Organisation for Research and Treatment of Cancer - EORTC; AmgenTerminatedLung Cancer Non-small Cell Stage IVIreland, Spain, Switzerland, United Kingdom, France, Austria, Slovenia, Belgium, Italy, Germany, Poland
-
Edward PatzActive, not recruitingNon-small Cell Lung CancerUnited States
-
TheRas, Inc., d/b/a BridgeBio Oncology TherapeuticsRecruitingNSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12CUnited States, Australia
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
Emory UniversityBristol-Myers SquibbWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCActive, not recruitingMetastatic Non Small Cell Lung Cancer | Recurrent Non Small Cell Lung CancerUnited States
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small Cell | Non-Small-Cell Lung CancerUnited States, Canada, Poland
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Bronchoalveolar Cell Lung CancerUnited States